Τετάρτη 19 Απριλίου 2017

Could using immunotherapy + targeted therapy based on genetic signatures become routine clinical practice? #BCC2017… https://t.co/7tPLOKzh8C

Could using immunotherapy + targeted therapy based on genetic signatures become routine clinical practice? #BCC2017… https://t.co/7tPLOKzh8C

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/854688997804830720
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις